ID   INP4A_MOUSE             Reviewed;         939 AA.
AC   Q9EPW0; Q8CBJ8;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   07-APR-2021, entry version 129.
DE   RecName: Full=Inositol polyphosphate-4-phosphatase type I A;
DE   AltName: Full=Inositol polyphosphate 4-phosphatase type I;
DE   AltName: Full=Inositol polyphosphate 4-phosphatase-1 {ECO:0000303|PubMed:19325558};
DE            Short=4-Ptase-1 {ECO:0000303|PubMed:19325558};
DE   AltName: Full=Type I inositol 3,4-bisphosphate 4-phosphatase;
DE            EC=3.1.3.66 {ECO:0000269|PubMed:20463662};
GN   Name=Inpp4a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   STRAIN=C57BL/6J;
RX   PubMed=11087841; DOI=10.1073/pnas.250476397;
RA   Vyas P., Norris F.A., Joseph R., Majerus P.W., Orkin S.H.;
RT   "Inositol polyphosphate 4-phosphatase type I regulates cell growth
RT   downstream of transcription factor GATA-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:13696-13701(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Cerebellum;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=11485317; DOI=10.1006/bbrc.2001.5331;
RA   Shearn C.T., Walker J., Norris F.A.;
RT   "Identification of a novel spliceoform of inositol polyphosphate 4-
RT   phosphatase type Ialpha expressed in human platelets: structure of human
RT   inositol polyphosphate 4-phosphatase type I gene.";
RL   Biochem. Biophys. Res. Commun. 286:119-125(2001).
RN   [4]
RP   CATALYTIC ACTIVITY, DISRUPTION PHENOTYPE, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=20463662; DOI=10.1038/nature09023;
RA   Sasaki J., Kofuji S., Itoh R., Momiyama T., Takayama K., Murakami H.,
RA   Chida S., Tsuya Y., Takasuga S., Eguchi S., Asanuma K., Horie Y., Miura K.,
RA   Davies E.M., Mitchell C., Yamazaki M., Hirai H., Takenawa T., Suzuki A.,
RA   Sasaki T.;
RT   "The PtdIns(3,4)P(2) phosphatase INPP4A is a suppressor of excitotoxic
RT   neuronal death.";
RL   Nature 465:497-501(2010).
RN   [5]
RP   FUNCTION.
RX   PubMed=19325558; DOI=10.1038/embor.2009.28;
RA   Ivetac I., Gurung R., Hakim S., Horan K.A., Sheffield D.A., Binge L.C.,
RA   Majerus P.W., Tiganis T., Mitchell C.A.;
RT   "Regulation of PI(3)K/Akt signalling and cellular transformation by
RT   inositol polyphosphate 4-phosphatase-1.";
RL   EMBO Rep. 10:487-493(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   INTERACTION WITH INPP5F.
RX   PubMed=25869668; DOI=10.1083/jcb.201409064;
RA   Nakatsu F., Messa M., Nandez R., Czapla H., Zou Y., Strittmatter S.M.,
RA   De Camilli P.;
RT   "Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic
RT   pathway.";
RL   J. Cell Biol. 209:85-95(2015).
CC   -!- FUNCTION: Catalyzes the hydrolysis of the 4-position phosphate of
CC       phosphatidylinositol 3,4-bisphosphate (PubMed:20463662). Catalyzes also
CC       inositol 1,3,4-trisphosphate and inositol 1,4-bisphosphate (By
CC       similarity). Antagonizes the PI3K-AKT/PKB signaling pathway by
CC       dephosphorylating phosphoinositides and thereby modulating cell cycle
CC       progression and cell survival (PubMed:11087841, PubMed:19325558). May
CC       protect neurons from excitotoxic cell death by regulating the synaptic
CC       localization of cell surface N-methyl-D-aspartate-type glutamate
CC       receptors (NMDARs) and NMDAR-mediated excitatory postsynaptic current
CC       (PubMed:20463662). {ECO:0000250|UniProtKB:Q62784,
CC       ECO:0000269|PubMed:11087841, ECO:0000269|PubMed:19325558,
CC       ECO:0000269|PubMed:20463662}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-
CC         bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol-3-phosphate) + phosphate; Xref=Rhea:RHEA:17193,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:57658,
CC         ChEBI:CHEBI:58088; EC=3.1.3.66;
CC         Evidence={ECO:0000269|PubMed:20463662};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 3,4-bisphosphate + H2O = 1D-myo-inositol 3-
CC         phosphate + phosphate; Xref=Rhea:RHEA:43388, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58401, ChEBI:CHEBI:83241;
CC         Evidence={ECO:0000250|UniProtKB:Q62784};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43389;
CC         Evidence={ECO:0000250|UniProtKB:Q62784};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 1,3,4-trisphosphate + H2O = 1D-myo-inositol
CC         1,3-bisphosphate + phosphate; Xref=Rhea:RHEA:43392,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58414,
CC         ChEBI:CHEBI:83242; Evidence={ECO:0000250|UniProtKB:Q62784};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43393;
CC         Evidence={ECO:0000250|UniProtKB:Q62784};
CC   -!- PATHWAY: Signal transduction; phosphatidylinositol signaling pathway.
CC   -!- SUBUNIT: Interacts with INPP5F. {ECO:0000269|PubMed:25869668}.
CC   -!- SUBCELLULAR LOCATION: Early endosome membrane
CC       {ECO:0000250|UniProtKB:Q96PE3}. Recycling endosome membrane
CC       {ECO:0000250|UniProtKB:Q96PE3}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q96PE3}. Nucleus {ECO:0000250|UniProtKB:Q96PE3}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q96PE3}. Cell junction, synapse,
CC       postsynaptic density {ECO:0000269|PubMed:20463662}. Note=Translocates
CC       to the plasma membrane upon EGF stimulation (By similarity). Shuttles
CC       between the cytoplasm and the nucleus, depending on the cell cycle
CC       stage, with highest amounts detected in the nucleus during the
CC       G0/G1phase (By similarity). {ECO:0000250|UniProtKB:Q96PE3}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9EPW0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9EPW0-2; Sequence=VSP_015243, VSP_015244, VSP_015245,
CC                                  VSP_015246;
CC   -!- TISSUE SPECIFICITY: Spleen, skeletal muscle, lung and uterus.
CC       {ECO:0000269|PubMed:11485317}.
CC   -!- DISRUPTION PHENOTYPE: Deficient mice are born at the expected Mendelian
CC       ratio and are indistinguishable from wild-type at birth. However, at
CC       about 14 days after birth, the growth rate of the mice slow
CC       significantly and all mutants died by the fourth week. At about 12 days
CC       after birth mice are unable to walk. In addition mice show extensive
CC       neurodegeneration accompanied by involuntary movements atarting at
CC       about 14 days after birth. {ECO:0000269|PubMed:20463662}.
CC   -!- SIMILARITY: Belongs to the inositol 3,4-bisphosphate 4-phosphatase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF317838; AAG40778.1; -; mRNA.
DR   EMBL; AK035867; BAC29220.1; -; mRNA.
DR   CCDS; CCDS35539.1; -. [Q9EPW0-1]
DR   CCDS; CCDS78570.1; -. [Q9EPW0-2]
DR   RefSeq; NP_001277726.1; NM_001290797.1.
DR   RefSeq; NP_001277727.1; NM_001290798.1.
DR   RefSeq; NP_001277728.1; NM_001290799.1.
DR   RefSeq; NP_084542.2; NM_030266.4.
DR   RefSeq; NP_766559.2; NM_172971.3.
DR   SMR; Q9EPW0; -.
DR   BioGRID; 234616; 1.
DR   IntAct; Q9EPW0; 3.
DR   MINT; Q9EPW0; -.
DR   STRING; 10090.ENSMUSP00000110583; -.
DR   SwissLipids; SLP:000000901; -.
DR   iPTMnet; Q9EPW0; -.
DR   PhosphoSitePlus; Q9EPW0; -.
DR   SwissPalm; Q9EPW0; -.
DR   PaxDb; Q9EPW0; -.
DR   PeptideAtlas; Q9EPW0; -.
DR   PRIDE; Q9EPW0; -.
DR   ProteomicsDB; 269225; -. [Q9EPW0-1]
DR   ProteomicsDB; 269226; -. [Q9EPW0-2]
DR   GeneID; 269180; -.
DR   KEGG; mmu:269180; -.
DR   CTD; 3631; -.
DR   MGI; MGI:1931123; Inpp4a.
DR   eggNOG; KOG4428; Eukaryota.
DR   InParanoid; Q9EPW0; -.
DR   Reactome; R-MMU-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-MMU-1660516; Synthesis of PIPs at the early endosome membrane.
DR   Reactome; R-MMU-1855183; Synthesis of IP2, IP, and Ins in the cytosol.
DR   UniPathway; UPA00944; -.
DR   BioGRID-ORCS; 269180; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Inpp4a; mouse.
DR   PRO; PR:Q9EPW0; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q9EPW0; protein.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031965; C:nuclear membrane; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0017161; F:inositol-1,3,4-trisphosphate 4-phosphatase activity; IEA:RHEA.
DR   GO; GO:0052828; F:inositol-3,4-bisphosphate 4-phosphatase activity; IEA:RHEA.
DR   GO; GO:0016316; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; IBA:GO_Central.
DR   GO; GO:0034597; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006798; P:polyphosphate catabolic process; TAS:MGI.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR039034; INPP4.
DR   PANTHER; PTHR12187; PTHR12187; 2.
DR   PROSITE; PS50004; C2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cytoplasm; Endosome;
KW   Hydrolase; Membrane; Nucleus; Phosphoprotein; Reference proteome; Synapse.
FT   CHAIN           1..939
FT                   /note="Inositol polyphosphate-4-phosphatase type I A"
FT                   /id="PRO_0000190233"
FT   DOMAIN          26..153
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   ACT_SITE        857
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:Q96PE3"
FT   MOD_RES         355
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96PE3"
FT   MOD_RES         488
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   VAR_SEQ         1..265
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_015243"
FT   VAR_SEQ         266..272
FT                   /note="LLEEDAA -> MCVCFAC (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_015244"
FT   VAR_SEQ         575..585
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_015245"
FT   VAR_SEQ         897..939
FT                   /note="EGCRRENTMKNVGSRKYAFNSLQLKAFPKHYRPPEGTYGKVET -> IGTRE
FT                   VVTQKNLSGLVPIRDLRLDPSLLCSIPLLALSPNLLIVWLFLSIAYLVTKLRCK (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_015246"
FT   CONFLICT        529
FT                   /note="Q -> E (in Ref. 2; BAC29220)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        553
FT                   /note="D -> E (in Ref. 2; BAC29220)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        717
FT                   /note="S -> N (in Ref. 2; BAC29220)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        741
FT                   /note="V -> F (in Ref. 2; BAC29220)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        744
FT                   /note="F -> L (in Ref. 2; BAC29220)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        783
FT                   /note="G -> V (in Ref. 2; BAC29220)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        786
FT                   /note="G -> V (in Ref. 2; BAC29220)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        792
FT                   /note="V -> L (in Ref. 2; BAC29220)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   939 AA;  105540 MW;  FBF3750836FA8962 CRC64;
     MTAREHSPRH GARARAMQRA STIDVAADMV GLSLAGNIQD PDEPILEFSL ACSELHTPSL
     DRKPNSFVAV SVTTPPQAFW TKHAQTEIIE GTNNPIFLSS IAFFQDSLIN QMTQIKLSVY
     DVKDRSQGTM YLLGSGTFVV KDLLQDRHHR LHLTLRSAES DRVGNITVIG WQMEEKSDQQ
     PPVTRFLDTV NGRMVLPVDE SLTEALGIRS KYAFLRKDSL LKAVFGGAIC RMYRFPTTDG
     NHLRILEQMA ESVLSLHVPR QFVKLLLEED AARVCELEEL GELSPCWESL RRQIVTQYQT
     IILTYQENLT DLHQYKGPSF KASSLKADKK LEFVPTNLHI QRMRVQDDGG SDQNYDVVTI
     GAPAAHCQGF KSGGLRKKLH KFEEAKKHSF EECCTSSSGQ SIIYIPQDIT RAKEIIAQIN
     TLKTQVSYYA ERLSRAAKDR SATGLERTLA ILADKTRQLV TVCDCKLLAN SIHGLNAARP
     DYIASKASPT STEEEQVMLR NDQDTLMARW AGRSSRSSLQ VDWHEEEWQK VWLNVDKSLE
     CIIQRVDKLL QKDRLHGEGC EDAFPCSSTC SSKKDCSPPP EESSPGEWSE ALYPLLTTLT
     DCVAMMSDKA KAAMVFLLMQ DSAPTIASYL SLQYRRDVVF CQTLTALICG FIIKLRNCLH
     DGGFLRQLYT IGLLAQFESL LSTYGEELAM LEDMSLGIMD LRNVTFKVTQ ATSNASSDML
     PVITGNRDGF NVRIPLPGPL VDSFPREIQS GMLLRVQPVL FNVGINEQQT LAERFGDTSL
     QEGINGESLV RVNSYFEQFK EVLPEDCLPR SRSQTCLPEL LRFLGQNVHA RKNKNVDILW
     QAAEVCRRLN GVRFTSCKSA KDRTAMSVTL EQCLILQHEH GMAPQVFTQA LECMRSEGCR
     RENTMKNVGS RKYAFNSLQL KAFPKHYRPP EGTYGKVET
//
